Versant Vantage I GP-GP, LLC 4

Accession 0000899243-21-004263

CIK 0001808158other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 6:43 PM ET

Size

52.8 KB

Accession

0000899243-21-004263

Insider Transaction Report

Form 4

Period: 2021-01-29

Repare Therapeutics Inc.RPTX

Versant Vantage I, L.P.

10% Owner

Transactions

Other
Common Shares
2021-01-29−263,278→ 2,114,947 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+56,868→ 56,868 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−7,919→ 63,619 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+1,711→ 58,579 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−8,766→ 70,422 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+1,893→ 60,472 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−60,472→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+4,328→ 4,328 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+751→ 751 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+5,000→ 5,000 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−4,313→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+745→ 745 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−250,000→ 2,894,451 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−5,000→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+4,313→ 4,313 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−50,000→ 508,282 total
Other
Common Shares
2021-01-29−751→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−20,037→ 160,958 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−4,328→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−745→ 0 total(indirect: See Footnote)

Versant Vantage I GP, L.P.

10% Owner

Transactions

Other
Common Shares
2021-01-29−745→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+4,328→ 4,328 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+4,313→ 4,313 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+751→ 751 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−8,766→ 70,422 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−60,472→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−20,037→ 160,958 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−250,000→ 2,894,451 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−50,000→ 508,282 total
Other
Common Shares
2021-01-29−751→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+745→ 745 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+56,868→ 56,868 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+1,893→ 60,472 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+5,000→ 5,000 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−263,278→ 2,114,947 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−7,919→ 63,619 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+1,711→ 58,579 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−4,328→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−5,000→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−4,313→ 0 total(indirect: See Footnote)

Versant Vantage I GP-GP, LLC

10% Owner

Transactions

Other
Common Shares
2021-01-29+56,868→ 56,868 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−4,328→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+5,000→ 5,000 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−7,919→ 63,619 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+1,711→ 58,579 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+751→ 751 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−745→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−60,472→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−20,037→ 160,958 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+4,328→ 4,328 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+4,313→ 4,313 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−263,278→ 2,114,947 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+1,893→ 60,472 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−250,000→ 2,894,451 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−5,000→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−4,313→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−8,766→ 70,422 total(indirect: See Footnote)
Other
Common Shares
2021-01-29−50,000→ 508,282 total
Other
Common Shares
2021-01-29−751→ 0 total(indirect: See Footnote)
Other
Common Shares
2021-01-29+745→ 745 total(indirect: See Footnote)

Footnotes (32)

[F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V, L.P. ("VVC V"), to its partners, pursuant to a Rule 10b5-1 trading plan.
[F10]Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I.
[F11]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members.
[F12]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V (Canada) LP ("VVC V (Canada)"), to its partners, pursuant to a Rule 10b5-1 trading plan.
[F13]Shares held by VVC V (Canada). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F14]Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada).
[F15]Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F16]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners.
[F17]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("VVC VI"), to its partners, pursuant to a Rule 10b5-1 trading plan.
[F18]Shares held by VVC VI. Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F19]Represents a change in the form of ownership of VV VI by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC VI.
[F2]Shares held by VVC V. Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F20]Shares held by VV VI. VV VI GP is the sole general partner of VV VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI. Each of VV VI GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F21]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI, to its partners.
[F22]Represents a change in the form of ownership of VV VI GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV VI.
[F23]Shares held by VV VI GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VV VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F24]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI GP, to its members.
[F25]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Vantage I, L.P. ("VV I"), to its partners, pursuant to a Rule 10b5-1 trading plan.
[F26]Shares held by VV I. Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F27]Represents a change in the form of ownership of VV I GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I.
[F28]Shares held by VV I GP. VV I GP-GP is the sole general partner of VV I GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP. Each of VV I GP-GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I GP, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F29]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP, to its partners.
[F3]Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V.
[F30]Represents a change in the form of ownership of VV I GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV I GP.
[F31]Shares held by VV I GP-GP. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F32]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV I GP-GP, to its members.
[F4]Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Affiliates Fund V, L.P. ("VAF V"), to its partners, pursuant to a Rule 10b5-1 trading plan.
[F6]Shares held by VAF V. VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
[F7]Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V.
[F8]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I"), to its partners, pursuant to a Rule 10b5-1 trading plan.
[F9]Shares held by VOAF I. VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing member of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Repare Therapeutics Inc.

CIK 0001808158

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001777653

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 6:43 PM ET
Size: 52.8 KB

View on SEC.gov